Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published on 16 October 2024.
From Stephen: Rogue telehealth provider Burst Health exited the New Zealand market in 2024 after a warning from Medsafe for its direct marketing of weight-loss drugs Saxenda, Contrave and Duromine on social media. But the story was a real team effort and started with former Pharmacy Today reporter Natasha Jojoa Burling’s initial story on the company’s questionable practices in November 2023. New Zealand Doctor Rata Aotearoa then picked up the ball and wrote a series of articles and following complaints by people in the health sector
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
